Ibrance Drug Interactions: 381 Major, 317 Moderate
Ibrance (Palbociclib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ibrance. Always confirm against the full prescribing information.
100 interactions
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Palbociclib.
Level 1 evidence
Acetylcholine
The risk or severity of adverse effects can be increased when Palbociclib is combined with Acetylcholine.
Level 2 evidence
Acyclovir
The risk or severity of adverse effects can be increased when Palbociclib is combined with Acyclovir.
Level 2 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Palbociclib.
Level 2 evidence
Albendazole
The metabolism of Palbociclib can be decreased when combined with Albendazole.
Level 2 evidence
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Palbociclib.
Level 1 evidence
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Palbociclib.
Level 1 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Palbociclib.
Level 1 evidence
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Palbociclib.
Level 1 evidence
Amantadine
The risk or severity of adverse effects can be increased when Palbociclib is combined with Amantadine.
Level 2 evidence
Ambrisentan
The serum concentration of Ambrisentan can be increased when it is combined with Palbociclib.
Level 2 evidence
Amiodarone
The metabolism of Palbociclib can be decreased when combined with Amiodarone.
Level 1 evidence
Enter your NPI to unlock 36 major interactions for Ibrance
Ibrance (Palbociclib) has 1017 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ibrance (Palbociclib) has 381 major, 317 moderate, and 319 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ibrance. Always confirm against the full prescribing information.